The American College of Rheumatology recommends biosimilar use in new white paper


(American College of Rheumatology) The ACR has published a new white paper that provides a comprehensive overview of the scientific, clinical, economic and prescribing issues pertaining to biosimilar use. The paper encourages providers to incorporate these drugs into treatment plans of patients with rheumatic diseases.